Crossmark

Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia

Crossref DOI link: https://doi.org/10.1186/s12885-019-5411-0

Published Online: 2019-03-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Richter, Anna

Roolf, Catrin

Hamed, Mohamed

Gladbach, Yvonne Saara

Sender, Sina

Konkolefski, Christoph

Knübel, Gudrun

Sekora, Anett

Fuellen, Georg

Vollmar, Brigitte

Murua Escobar, Hugo

Junghanss, Christian
Funding

Funding for this research was provided by:

University of Rostock FORUN Grant (-)

Federal State of Mecklenburg-Vorpommern (-)
License Information

Text and Data Mining valid from 2019-03-06
More Information

Article History

Received: 19 October 2018

Accepted: 26 February 2019

First Online: 6 March 2019

Ethics approval and consent to participate

: The study was performed in accordance to the Declaration of Helsinki and the local ethical standards of the Rostock University Medical Center.All animal experiments were approved by the review board of the federal state of Mecklenburg-Vorpommern, Germany (reference number: LALLF MV/7221.3–1.1-002/15).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.